Oregon · House Bill 2103 · 2025 Regular Session
Directs the State Board of Pharmacy to adopt rules to classify xylazine as a Schedule IV controlled substance.
- Introduced Jan 13, 2025
- In committee Jan 17, 2025
- Died
- Passed the Senate
- To the governor
- Became law
What it does
The legislature's own summary of the bill, or its official long title.
The Act tells the State Board of Pharmacy to classify xylazine as a Schedule IV controlled substance. (Flesch Readability Score: 60.1). Directs the State Board of Pharmacy to adopt rules to classify xylazine as a Schedule IV controlled substance.
Every action
3 steps, oldest first, as the legislature records them.
- HouseFirst reading. Referred to Speaker's desk.
- CommitteeReferred to Behavioral Health and Health Care. · House Behavioral Health and Health Care
- HouseIn committee upon adjournment.
Roll calls
No recorded votes on this bill yet.
Sponsors
The member who introduced it.
-
Virgle OsborneR Primary sponsor · District 2
From Oregon's official records (api.oregonlegislature.gov), checked Nov 13, 2026. Text links go to the official versions; LegiList does not copy bill text.